Citations

Citations to this article as recorded by  

• Dedifferentiated Leiomyosarcoma of the Uterine Corpus with Heterologous Component: Clinicopathological Analysis of Five Consecutive Cases from a Single Institution and Comprehensive Literature Review
  Suyeon Kim, Hyunsik Bae, Hyun-Soo Kim
  Diagnostics.2024; 14(2): 160.     CrossRef
• Identification of Key Immune Infiltration Related Genes Involved in Aortic Dissection Using Bioinformatic Analyses and Experimental Verification
  Lin Zheng, Yusi Yang, Jie Liu, Tianliang Zhao, Xin Zhang, Lihua Chen
  Journal of Inflammation Research.2024; Volume 17: 2119.     CrossRef

Citations

Citations to this article as recorded by  

• Chitosan and Its Derivative-Based Nanoparticles in Gastrointestinal Cancers: Molecular Mechanisms of Action and Promising Anticancer Strategies
  Zahra Shokati Eshkiki, Fatemeh Mansouri, Amir Reza Karamzadeh, Abolfazl Namazi, Hafez Heydari, Javad Akhtari, Seidamir Pasha Tabaeian, Abolfazl Akbari, Hongda Liu
  Journal of Clinical Pharmacy and Therapeutics.2024; 2024: 1.     CrossRef
• A Standardized Pathology Report for Gastric Cancer: 2nd Edition
  Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi,
  Journal of Gastric Cancer.2023; 23(1): 107.     CrossRef
• A standardized pathology report for gastric cancer: 2nd edition
  Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi,
  Journal of Pathology and Translational Medicine.2023; 57(1): 1.     CrossRef
• Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
  Tae-Han Kim, In-Ho Kim, Seung Joo Kang, Miyoung Choi, Baek-Hui Kim, Bang Wool Eom, Bum Jun Kim, Byung-Hoon Min, Chang In Choi, Cheol Min Shin, Chung Hyun Tae, Chung sik Gong, Dong Jin Kim, Arthur Eung-Hyuck Cho, Eun Jeong Gong, Geum Jong Song, Hyeon-Su Im
  Journal of Gastric Cancer.2023; 23(1): 3.     CrossRef
• Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis
  Jina Choi, Nayoung Kim, Ryoung Hee Nam, Jin Won Kim, Chin-Hee Song, Hee Young Na, Gyeong Hoon Kang, Alvaro Galli
  PLOS ONE.2023; 18(2): e0282017.     CrossRef
• Comprehensive Analysis of Epigenetic Associated Genes with Differential Gene Expression and Prognosis in Gastric Cancer
  Songlin An, Xinbao Li, Bing Li, Yan Li
  Combinatorial Chemistry & High Throughput Screening.2023; 26(3): 527.     CrossRef
• Liquid Biopsy in Advanced Colorectal Cancer: Clinical Applications of Different Analytes
  Marco Donatello Delcuratolo, Andrea Modrego-Sánchez, Maristella Bungaro, Beatriz Antón-Pascual, Santiago Teran, Valentina Dipace, Silvia Novello, Rocio Garcia-Carbonero, Francesco Passiglia, Cristina Graválos-Castro
  Journal of Molecular Pathology.2023; 4(3): 128.     CrossRef
• Exosomal circ_0001190 Regulates the Progression of Gastric Cancer via miR-586/SOSTDC1 Axis
  Chao Liu, Jing Yang, Fengchi Zhu, Zhiying Zhao, Lixue Gao
  Biochemical Genetics.2022; 60(6): 1895.     CrossRef
• Optimization of pre‐analytical and analytical steps for DNA and RNA analysis of fresh cytology samples
  Ana Dolinar, Gašper Grubelnik, Irena Srebotnik‐Kirbiš, Margareta Strojan Fležar, Margareta Žlajpah
  Cancer Medicine.2022; 11(21): 4021.     CrossRef
• Retracted: Connexin 43 upregulation by dioscin‐inhibited gastric cancer metastasis by suppressing PI3K/Akt pathway
  
  Food Science & Nutrition.2022;[Epub]     CrossRef
• Molecular Pathology of Gastric Cancer
  Moonsik Kim, An Na Seo
  Journal of Gastric Cancer.2022; 22(4): 264.     CrossRef
• Case report: Undifferentiated sarcoma with multiple tumors involved in Lynch syndrome: Unexpected favorable outcome to sintilimab combined with chemotherapy
  Jiaying Liu, Xiaona Chang, Guixiang Xiao, Jingmin Zhong, Bo Huang, Jiwei Zhang, Beibei Gao, Gang Peng, Xiu Nie
  Frontiers in Oncology.2022;[Epub]     CrossRef
• The SUMO E3 ligase CBX4 is identified as a poor prognostic marker of gastric cancer through multipronged OMIC analyses
  Yi Pan, Qingshang Li, Zhijun Cao, Shuliang Zhao
  Genes & Diseases.2021; 8(6): 827.     CrossRef
• Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas
  George Kunnackal John, Vipin Das Villgran, Christine Caufield-Noll, Francis Giardiello
  Familial Cancer.2021; 20(2): 145.     CrossRef
• Tamoxifen Downregulates the Expression of Notch1 and DLL1 Genes in MKN-45 Gastric Cancer Cells
  Faranak Khanipouyani, Hassan Akrami
  Journal of Gastrointestinal Cancer.2021; 52(3): 922.     CrossRef
• Kallikrein-11, in Association with Coiled-Coil Domain Containing 25, as a Potential Prognostic Marker for Cholangiocarcinoma with Lymph Node Metastasis
  Saeranee Siriphak, Ravinnipa Chanakankun, Tanakorn Proungvitaya, Sittiruk Roytrakul, Doungdean Tummanatsakun, Wunchana Seubwai, Molin Wongwattanakul, Siriporn Proungvitaya
  Molecules.2021; 26(11): 3105.     CrossRef
• ISH-based HER2 diagnostics
  Josef Rüschoff, Iris Nagelmeier, Bharat Jasani, Oliver Stoss
  Der Pathologe.2021; 42(S1): 62.     CrossRef
• Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics
  Zhao Liu, Shihai Liu, Jing Guo, Libin Sun, Shasha Wang, Yixuan Wang, Wensheng Qiu, Jing Lv
  Genetic Testing and Molecular Biomarkers.2021; 25(1): 1.     CrossRef
• Microsatellite Instability in Colorectal Cancer Liquid Biopsy—Current Updates on Its Potential in Non-Invasive Detection, Prognosis and as a Predictive Marker
  Francis Yew Fu Tieng, Nadiah Abu, Learn-Han Lee, Nurul-Syakima Ab Mutalib
  Diagnostics.2021; 11(3): 544.     CrossRef
• Metformin attenuates synergic effect of diabetes mellitus and Helicobacter pylori infection on gastric cancer cells proliferation by suppressing PTEN expression
  Huibin Lu, Xinwei Han, Jianzhuang Ren, Kewei Ren, Zongming Li, Quanhui Zhang
  Journal of Cellular and Molecular Medicine.2021; 25(10): 4534.     CrossRef
• Recent Advances in the Diagnosis, Staging, Treatment, and Prognosis of Advanced Gastric Cancer: A Literature Review
  Zhi-da Chen, Peng-fei Zhang, Hong-qing Xi, Bo Wei, Lin Chen, Yun Tang
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Tumor immune response and immunotherapy in gastric cancer
  Yoonjin Kwak, An Na Seo, Hee Eun Lee, Hye Seung Lee
  Journal of Pathology and Translational Medicine.2020; 54(1): 20.     CrossRef
• Comparative analysis of HER2 copy number between plasma and tissue samples in gastric cancer using droplet digital PCR
  Boram Kim, Soo Kyung Nam, Soo Hyun Seo, Kyoung Un Park, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
  Scientific Reports.2020;[Epub]     CrossRef
• Differential prognostic impact of CD8+ T cells based on human leucocyte antigen I and PD-L1 expression in microsatellite-unstable gastric cancer
  Yoonjin Kwak, Jiwon Koh, Yujun Park, Yun Ji Hong, Kyoung Un Park, Hyung-Ho Kim, Do Joong Park, Sang-Hoon Ahn, Woo Ho Kim, Hye Seung Lee
  British Journal of Cancer.2020; 122(9): 1399.     CrossRef
• High-Accuracy Determination of Microsatellite Instability Compatible with Liquid Biopsies
  Amanda Bortolini Silveira, François-Clément Bidard, Amélie Kasperek, Samia Melaabi, Marie-Laure Tanguy, Manuel Rodrigues, Guillaume Bataillon, Luc Cabel, Bruno Buecher, Jean-Yves Pierga, Charlotte Proudhon, Marc-Henri Stern
  Clinical Chemistry.2020; 66(4): 606.     CrossRef
• Chitosan: A compound for drug delivery system in gastric cancer-a review
  Rana Shafabakhsh, Bahman Yousefi, Zatollah Asemi, Banafsheh Nikfar, Mohammad Ali Mansournia, Jamal Hallajzadeh
  Carbohydrate Polymers.2020; 242: 116403.     CrossRef
• MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy
  Maria Grazia Rodriquenz, Giandomenico Roviello, Alberto D’Angelo, Daniele Lavacchi, Franco Roviello, Karol Polom
  Journal of Clinical Medicine.2020; 9(5): 1427.     CrossRef
• Theoretical calculations of molecular descriptors for anticancer activities of 1, 2, 3-triazole-pyrimidine derivatives against gastric cancer cell line (MGC-803): DFT, QSAR and docking approaches
  Rhoda Oyeladun Oyewole, Abel Kolawole Oyebamiji, Banjo Semire
  Heliyon.2020; 6(5): e03926.     CrossRef
• Identification of a Clinical Cutoff Value for Multiplex KRASG12/G13 Mutation Detection in Colorectal Adenocarcinoma Patients Using Digital Droplet PCR, and Comparison with Sanger Sequencing and PNA Clamping Assay
  Kyung Ha Lee, Tae Hee Lee, Min Kyung Choi, In Sun Kwon, Go Eun Bae, Min-Kyung Yeo
  Journal of Clinical Medicine.2020; 9(7): 2283.     CrossRef
• PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
  Yujun Park, Jiwon Koh, Hee Young Na, Yoonjin Kwak, Keun-Wook Lee, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee
  Cancer Research and Treatment.2020; 52(3): 661.     CrossRef
• Clinical and Molecular Assessment of Patients with Lynch Syndrome and Sarcomas Underpinning the Association with MSH2 Germline Pathogenic Variants
  Nathália de Angelis de Carvalho, Bianca Naomi Niitsuma, Vanessa Nascimento Kozak, Felipe D’almeida Costa, Mariana Petaccia de Macedo, Bruna Elisa Catin Kupper, Maria Letícia Gobo Silva, Maria Nirvana Formiga, Sahlua Miguel Volc, Samuel Aguiar Junior, Eden
  Cancers.2020; 12(7): 1848.     CrossRef
• Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis
  Junhui Yu, Shan Li, Jing Guo, Zhengshui Xu, Jianbao Zheng, Xuejun Sun
  Cell Death & Disease.2020;[Epub]     CrossRef
• YAP promotes self-renewal of gastric cancer cells by inhibiting expression of L-PTGDS and PTGDR2
  Qingli Bie, Xiaozhe Li, Shiqi Liu, Xiao Yang, Zhenwen Qian, Rou Zhao, Xiaobei Zhang, Bin Zhang
  International Journal of Clinical Oncology.2020; 25(12): 2055.     CrossRef
• ISH-basierte HER2-Diagnostik
  Josef Rüschoff, Iris Nagelmeier, Bharat Jasani, Oliver Stoss
  Der Pathologe.2020; 41(6): 606.     CrossRef
• Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells
  Xinli An, Zekun Wei, Botian Ran, Hao Tian, Hongyu Gu, Yan Liu, Hongjuan Cui, Shunqin Zhu
  Anti-Cancer Agents in Medicinal Chemistry.2020; 20(17): 2114.     CrossRef
• Role of Her-2 in Gastrointestinal Tumours beyond Gastric Cancer: A Tool for Precision Medicine
  Csongor G. Lengyel, Baker Habeeb, Shah Z. Khan, Khalid El Bairi, Sara C. Altuna, Sadaqat Hussain, Syed Ayub Mazher, Dario Trapani, Angelica Petrillo
  Gastrointestinal Disorders.2020; 3(1): 1.     CrossRef
• Next-generation Sequencing in the Management of Gastric and Esophageal Cancers
  Jill C. Rubinstein, Norman G. Nicolson, Nita Ahuja
  Surgical Clinics of North America.2019; 99(3): 511.     CrossRef
• Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy
  Tania Fleitas-Kanonnikoff, Carolina Martinez‐Ciarpaglini, Josefina Ayala, Cinthia Gauna, Rita Denis, Ita Yoffe, Silvia Sforza, María Teresa Martínez, Alicia Pomata, Maider Ibarrola‐Villava, Sipan Arevshatyan, Verónica Burriel, Diego Boscá, Oscar Pastor, A
  Cancer Medicine.2019; 8(6): 3120.     CrossRef
• Human epidermal growth factor receptor 2-positive digestive tumors
  Anna D. Wagner, Berna C. Özdemir, Josef Rüschoff
  Current Opinion in Oncology.2019; 31(4): 354.     CrossRef
• Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications
  Carolina Martinez-Ciarpaglini, Tania Fleitas-Kanonnikoff, Valentina Gambardella, Marta Llorca, Cristina Mongort, Regina Mengual, Gema Nieto, Lara Navarro, Marisol Huerta, Susana Rosello, Desamparados Roda, Noelia Tarazona, Samuel Navarro, Gloria Ribas, An
  ESMO Open.2019; 4(3): e000470.     CrossRef
• Current and future molecular diagnostics of gastric cancer
  Rachel Sin-Yu Choi, Wing Yin Xenia Lai, Lok Ting Claire Lee, Wing Lam Christa Wong, Xiao Meng Pei, Hin Fung Tsang, Joel Johnson Leung, William Chi Shing Cho, Man Kee Maggie Chu, Elaine Yue Ling Wong, Sze Chuen Cesar Wong
  Expert Review of Molecular Diagnostics.2019; 19(10): 863.     CrossRef
• Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer
  Yujun Park, Jiwon Koh, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
  Cancer Immunology, Immunotherapy.2019; 68(11): 1779.     CrossRef
• Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications
  Jiwon Koh, Keun-Wook Lee, Soo Kyung Nam, An Na Seo, Ji-Won Kim, Jin Won Kim, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
  The Oncologist.2019; 24(12): e1321.     CrossRef
• Mechanisms and Therapy for Cancer Metastasis to the Brain
  Federica Franchino, Roberta Rudà, Riccardo Soffietti
  Frontiers in Oncology.2018;[Epub]     CrossRef
• Status of programmed death-ligand 1 expression in sarcomas
  Hyung Kyu Park, Mingi Kim, Minjung Sung, Seung Eun Lee, Yu Jin Kim, Yoon-La Choi
  Journal of Translational Medicine.2018;[Epub]     CrossRef
• Design and synthesis of near-infrared fluorescence-enhancement probes for the cancer-specific enzyme hNQO1
  Changyu Zhang, Bei-Bei Zhai, Tao Peng, Zelin Zhong, Lianbin Xu, Qiang-Zhe Zhang, Lu-Yuan Li, Long Yi, Zhen Xi
  Dyes and Pigments.2017; 143: 245.     CrossRef
• Progress in the treatment of advanced gastric cancer
  Zheyu Song, Yuanyu Wu, Jiebing Yang, Dingquan Yang, Xuedong Fang
  Tumor Biology.2017; 39(7): 101042831771462.     CrossRef
• Pathologische Einteilung und Diagnostik des Ösophagus- und Magenkarzinoms
  S. Förster, A. Tannapfel
  Der Gastroenterologe.2017; 12(5): 394.     CrossRef
• NR4A1-induced increase in the sensitivity of a human gastric cancer line to TNFα-mediated apoptosis is associated with the inhibition of JNK/Parkin-dependent mitophagy
  Hongzhu Yan, Feng Xiao, Jue Zou, Chengmin Qiu, Weiwei Sun, Minmin Gu, Li Zhang
  International Journal of Oncology.2017;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Artificial Intelligence in Lung Cancer Imaging: From Data to Therapy
  Michaela Cellina, Giuseppe De Padova, Nazarena Caldarelli, Dario Libri, Maurizio Cè, Carlo Martinenghi, Marco Alì, Sergio Papa, Gianpaolo Carrafiello
  Critical Reviews™ in Oncogenesis.2024; 29(2): 1.     CrossRef
• Artificial Intelligence for Cardiothoracic Imaging: Overview of Current and Emerging Applications
  Bruno Hochhegger, Romulo Pasini, Alysson Roncally Carvalho, Rosana Rodrigues, Stephan Altmayer, Leonardo Kayat Bittencourt, Edson Marchiori, Reza Forghani
  Seminars in Roentgenology.2023; 58(2): 184.     CrossRef
• Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study
  Diego F. Chamorro, Andrés F. Cardona, July Rodríguez, Alejandro Ruiz-Patiño, Oscar Arrieta, Darwin A. Moreno-Pérez, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, Dora V. Ardila, Lucia Viola, Gonzalo Recondo, Juan B. Blaquier, Claudio Martín, Luis Raez, Su
  Targeted Oncology.2023; 18(3): 425.     CrossRef
• Histone deacetylase inhibitor belinostat regulates metabolic reprogramming in killing KRAS‐mutant human lung cancer cells
  Rebecca M. Peter, Md. Shahid Sarwar, Sarah Z. Mostafa, Yujue Wang, Xiaoyang Su, Ah‐Ng Kong
  Molecular Carcinogenesis.2023; 62(8): 1136.     CrossRef
• Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation Status
  Bihong T. Chen, Taihao Jin, Ningrong Ye, Sean W. Chen, Russell C. Rockne, Stephanie Yoon, Isa Mambetsariev, Ebenezer Daniel, Ravi Salgia
  Brain Sciences.2023; 13(7): 1057.     CrossRef
• Clinicopathological features and prognostic significance of pulmonary adenocarcinoma with signet ring cell components: meta-analysis and SEER analysis
  Yang Tan, Ying-he Huang, Jia-wen Xue, Rui Zhang, Run Liu, Yan Wang, Zhen-Bo Feng
  Clinical and Experimental Medicine.2023; 23(8): 4341.     CrossRef
• Ganoderma microsporum immunomodulatory protein as an extracellular epidermal growth factor receptor (EGFR) degrader for suppressing EGFR-positive lung cancer cells
  Wei-Jyun Hua, Hsin Yeh, Zhi-Hu Lin, Ai-Jung Tseng, Li-Chen Huang, Wei-Lun Qiu, Tsung-Hsi Tu, Ding-Han Wang, Wei-Hung Hsu, Wei-Lun Hwang, Tung-Yi Lin
  Cancer Letters.2023; 578: 216458.     CrossRef
• Next generation sequencing for detection of EGFR alterations in NSCLC: is more better?
  Ullas Batra, Shrinidhi Nathany, Mansi Sharma, Parveen Jain, Anurag Mehta
  Journal of Clinical Pathology.2022; 75(3): 164.     CrossRef
• Enkurin domain containing 1 (ENKD1) regulates the proliferation, migration and invasion of non‐small cell lung cancer cells
  Ting Song, Peng Zhou, Chunjiao Sun, Na He, Haixia Li, Jie Ran, Jun Zhou, Yue Wu, Min Liu
  Asia-Pacific Journal of Clinical Oncology.2022;[Epub]     CrossRef
• Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives
  Jia-Xin Li, Run-Ze Li, Lin-Rui Ma, Peng Wang, Dong-Han Xu, Jie Huang, Li-Qi Li, Ling Tang, Ying Xie, Elaine Lai-Han Leung, Pei-Yu Yan
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis
  Shuhei Ueshima, Jia Fang
  Oncogene.2022; 41(24): 3370.     CrossRef
• ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
  A. Passaro, N. Leighl, F. Blackhall, S. Popat, K. Kerr, M.J. Ahn, M.E. Arcila, O. Arrieta, D. Planchard, F. de Marinis, A.M. Dingemans, R. Dziadziuszko, C. Faivre-Finn, J. Feldman, E. Felip, G. Curigliano, R. Herbst, P.A. Jänne, T. John, T. Mitsudomi, T.
  Annals of Oncology.2022; 33(5): 466.     CrossRef
• Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?
  Begoña O. Alen, Lara S. Estévez-Pérez, María Teresa Hermida-Romero, Ana Reguera-Arias, Rosario García-Campelo, Mercedes de la Torre-Bravos, Ángel Concha
  Cancers.2022; 14(14): 3323.     CrossRef
• Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer
  Yock Ping Chow, Norziha Zainul Abidin, Ken Siong Kow, Lye Mun Tho, Chieh Lee Wong, Rama Krishna Kancha
  PLOS ONE.2022; 17(10): e0276161.     CrossRef
• Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement—Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors
  Ming-Hung Huang, Jih-Hsiang Lee, Pei-Shan Hung, James Chih-Hsin Yang
  JTO Clinical and Research Reports.2022; 3(11): 100405.     CrossRef
• Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future
  Michaela Cellina, Maurizio Cè, Giovanni Irmici, Velio Ascenti, Natallia Khenkina, Marco Toto-Brocchi, Carlo Martinenghi, Sergio Papa, Gianpaolo Carrafiello
  Diagnostics.2022; 12(11): 2644.     CrossRef
• A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice
  Yanxia Liu, Yuan Gao, Ying Wang, Cong Zhao, Zhiyun Zhang, Baolan Li, Tongmei Zhang
  BMC Cancer.2022;[Epub]     CrossRef
• High frequency of KRAS and EGFR mutation profiles in BRAF-negative thyroid carcinomas in Indonesia
  Didik Setyo Heriyanto, Vincent Laiman, Nikko Vanda Limantara, Widyan Putra Anantawikrama, Fara Silvia Yuliani, Rita Cempaka, Sumadi Lukman Anwar
  BMC Research Notes.2022;[Epub]     CrossRef
• Targeted next-generation sequencing for cancer-associated gene mutation and copy number detection in 206 patients with non–small-cell lung cancer
  Songbai Zheng, Xiaodan Wang, Ying Fu, Beibei Li, Jianhua Xu, Haifang Wang, Zhen Huang, Hui Xu, Yurong Qiu, Yaozhou Shi, Kui Li
  Bioengineered.2021; 12(1): 791.     CrossRef
• How mathematical modeling could contribute to the quantification of metastatic tumor burden under therapy: insights in immunotherapeutic treatment of non-small cell lung cancer
  Pirmin Schlicke, Christina Kuttler, Christian Schumann
  Theoretical Biology and Medical Modelling.2021;[Epub]     CrossRef
• A case of concomitant EGFR/ALK alteration against a mutated EGFR background in early-stage lung adenocarcinoma
  Ki-Chang Lee, Jiwon Koh, Doo Hyun Chung, Yoon Kyung Jeon
  Journal of Pathology and Translational Medicine.2021; 55(2): 139.     CrossRef
• Malfeasance of KRAS mutations in carcinogenesis
  Rupal Tripathi, Shrinidhi Nathany, Anurag Mehta, Ullas Batra, Sakshi Mattoo, Mansi Sharma
  Clinical and Experimental Medicine.2021; 21(3): 439.     CrossRef
• Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors
  Giorgia Nardo, Jessica Carlet, Ludovica Marra, Laura Bonanno, Alice Boscolo, Alessandro Dal Maso, Andrea Boscolo Bragadin, Stefano Indraccolo, Elisabetta Zulato
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma
  Valerio Gristina, Maria La Mantia, Antonio Galvano, Sofia Cutaia, Nadia Barraco, Marta Castiglia, Alessandro Perez, Marco Bono, Federica Iacono, Martina Greco, Katia Calcara, Valentina Calò, Sergio Rizzo, Lorena Incorvaia, Maria Chiara Lisanti, Giulia San
  Journal of Molecular Pathology.2021; 2(2): 173.     CrossRef
• Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets
  Mercedes L Dalurzo, Alejandro Avilés-Salas, Fernando Augusto Soares, Yingyong Hou, Yuan Li, Anna Stroganova, Büge Öz, Arif Abdillah, Hui Wan, Yoon-La Choi
  OncoTargets and Therapy.2021; Volume 14: 4671.     CrossRef
• Untangling the KRAS mutated lung cancer subsets and its therapeutic implications
  Kulshrestha Ritu, Pawan Kumar, Amit Singh, K. Nupur, Sonam Spalgias, Parul Mrigpuri, Rajkumar
  Molecular Biomedicine.2021;[Epub]     CrossRef
• Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report
  Janna-Lisa Velthaus, Peter Iglauer, Ronald Simon, Carsten Bokemeyer, Peter Bannas, Niklas Beumer, Charles D. Imbusch, Eray Goekkurt, Sonja Loges
  Oncology Research and Treatment.2021; 44(9): 495.     CrossRef
• Proteasome-dependent degradation of Smad7 is critical for lung cancer metastasis
  Lu Tong, Shihui Shen, Quan Huang, Junjiang Fu, Tianzhen Wang, Linian Pan, Pei Zhang, Geng Chen, Tingmei Huang, Ke Li, Qingwu Liu, Shaofang Xie, Xiao Yang, Robb E. Moses, Xiaotao Li, Lei Li
  Cell Death & Differentiation.2020; 27(6): 1795.     CrossRef
• Circulating cell-free DNA as a diagnostic and prognostic biomarker for non-small-cell lung cancer: a systematic review and meta-analysis
  Zhoumiao Chen, Huiwen Miao, Qingxin Zeng, Shaohua Xu, Zhao Chen, Kai Liu
  Biomarkers in Medicine.2020; 14(7): 587.     CrossRef
• Influence of EGFR-activating mutations on sensitivity to tyrosine kinase inhibitors in a KRAS mutant non-small cell lung cancer cell line
  Yoshinori Tsukumo, Mikihiko Naito, Takayoshi Suzuki, Srikumar Chellappan
  PLOS ONE.2020; 15(3): e0229712.     CrossRef
• KRAS oncogene may be another target conquered in non‐small cell lung cancer (NSCLC)
  Hanxiao Chen, Jun Zhao
  Thoracic Cancer.2020; 11(12): 3425.     CrossRef
• Epidemiologic Features of NSCLC Gene Alterations in Hispanic Patients from Puerto Rico
  Ruifang Zheng, Zhiwei Yin, Albert Alhatem, Derek Lyle, Bei You, Andrew S. Jiang, Dongfang Liu, Zsolt Jobbagy, Qing Wang, Seena Aisner, Jie-Gen Jiang
  Cancers.2020; 12(12): 3492.     CrossRef
• Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications
  Robin Imperial, Omer M Toor, Arif Hussain, Janakiraman Subramanian, Ashiq Masood
  Seminars in Cancer Biology.2019; 54: 14.     CrossRef
• Epidermal growth factor receptor (EGFR), KRAS, and BRAF mutations in lung adenocarcinomas: A study from India
  Varsha Singh, Prerna Guleria, Prabhat Singh Malik, Anant Mohan, Sanjay Thulkar, R M Pandey, Kalpana Luthra, Sudheer Arava, Ruma Ray, Deepali Jain
  Current Problems in Cancer.2019; 43(5): 391.     CrossRef
• Clinical Validation of Coexisting Activating Mutations Within EGFR, Mitogen-Activated Protein Kinase, and Phosphatidylinositol 3-Kinase Pathways in Lung Cancers
  Federico De Marchi, Lisa Haley, Henderson Fryer, Junaid Ibrahim, Katie Beierl, Gang Zheng, Christopher D. Gocke, James R. Eshleman, Deborah Belchis, Peter Illei, Ming-Tseh Lin
  Archives of Pathology & Laboratory Medicine.2019; 143(2): 174.     CrossRef
• A sequential Monte Carlo algorithm for inference of subclonal structure in cancer
  Oyetunji E. Ogundijo, Kaiyi Zhu, Xiaodong Wang, Dimitris Anastassiou, Xiang Li
  PLOS ONE.2019; 14(1): e0211213.     CrossRef
• The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients
  Anna Rachiglio, Francesca Fenizia, Maria Piccirillo, Domenico Galetta, Lucio Crinò, Bruno Vincenzi, Emiddio Barletta, Carmine Pinto, Francesco Ferraù, Matilde Lambiase, Agnese Montanino, Cristin Roma, Vienna Ludovini, Elisabetta Montagna, Antonella De Luc
  Cancers.2019; 11(3): 341.     CrossRef
• Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer
  Minjiang Chen, Yan Xu, Jing Zhao, Wei Zhong, Li Zhang, Yalan Bi, Mengzhao Wang
  EBioMedicine.2019; 42: 304.     CrossRef
• Anaplastic Lymphoma Kinase (ALK)-positive Tumors
  Rohan Gupta, Idoroenyi Amanam, Syed Rahmanuddin, Isa Mambetsariev, Yingyu Wang, Charity Huang, Karen Reckamp, Lalit Vora, Ravi Salgia
  American Journal of Clinical Oncology.2019; 42(4): 337.     CrossRef
• Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF
  Xibin Zhuang, Chao Zhao, Jiayu Li, Chunxia Su, Xiaoxia Chen, Shengxiang Ren, Xuefei Li, Caicun Zhou
  Cancer Medicine.2019; 8(6): 2858.     CrossRef
• Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
  Santoni-Rugiu, Melchior, Urbanska, Jakobsen, Stricker, Grauslund, Sørensen
  Cancers.2019; 11(7): 923.     CrossRef
• Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
  J. Chantharasamee, N. Poungvarin, P. Danchaivijitr, S. Techawatanawanna
  BMC Cancer.2019;[Epub]     CrossRef
• Deregulated lncRNA expression profile in the mouse lung adenocarcinomas with KRAS‐G12D mutation and P53 knockout
  Meiqin Zhang, Nan Jiang, Renjie Cui, Sichen Du, Huayuan Ou, Tinglan Chen, Runsheng Ge, Duan Ma, Jin Zhang
  Journal of Cellular and Molecular Medicine.2019; 23(10): 6978.     CrossRef
• Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes
  Erica K. Barnell, Adam Waalkes, Matt C. Mosior, Kelsi Penewit, Kelsy C. Cotto, Arpad M. Danos, Lana M. Sheta, Katie M. Campbell, Kilannin Krysiak, Damian Rieke, Nicholas C. Spies, Zachary L. Skidmore, Colin C. Pritchard, Todd A. Fehniger, Ravindra Uppalur
  JCO Clinical Cancer Informatics.2019; (3): 1.     CrossRef
• EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
  Maria Colombino, Panagiotis Paliogiannis, Antonio Cossu, Davide Adriano Santeufemia, Maria Cristina Sini, Milena Casula, Grazia Palomba, Antonella Manca, Marina Pisano, Valentina Doneddu, Giuseppe Palmieri
  BMC Pulmonary Medicine.2019;[Epub]     CrossRef
• Concomitant Presence of EGFR and ALK Fusion Gene Mutation in Adenocarcinoma of Lung: A Case Report and Review of the Literature
  Nishitha Thumallapally, Hana Yu, Mohammad Farhan, Uroosa Ibrahim, Maricel Odiami
  Journal of Pharmacy Practice.2018; 31(2): 244.     CrossRef
• Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC
  Nele Van Der Steen, Yves Mentens, Marc Ramael, Leticia G. Leon, Paul Germonpré, Jose Ferri, David R. Gandara, Elisa Giovannetti, Godefridus J. Peters, Patrick Pauwels, Christian Rolfo
  Clinical Lung Cancer.2018; 19(1): 35.     CrossRef
• KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target
  Marta Román, Iosune Baraibar, Inés López, Ernest Nadal, Christian Rolfo, Silvestre Vicent, Ignacio Gil-Bazo
  Molecular Cancer.2018;[Epub]     CrossRef
• Pulmonary Adenocarcinoma, Harboring Both an EGFR Mutation and ALK Rearrangement, Presenting a Stable Disease to Erlotinib and a Partial Response to Alectinib
  Akira Yokoyama, Atsuhisa Tamura, Kazuko Miyakawa, Kei Kusaka, Masahiro Shimada, Takashi Hirose, Hirotoshi Matsui, Masashi Kitani, Akira Hebisawa, Ken Ohta
  Internal Medicine.2018; 57(16): 2377.     CrossRef
• Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations
  Biagio Ricciuti, Sara Baglivo, Vienna Ludovini, Angelo Sidoni, Giulio Metro, Marta Brambilla, Annamaria Siggillino, Maria Sole Reda, Alberto Rebonato, Daniele Maiettini, Rita Chiari
  Lung Cancer.2018; 120: 70.     CrossRef
• Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment
  Jan Nyrop Jakobsen, Eric Santoni-Rugiu, Morten Grauslund, Linea Melchior, Jens Benn Sørensen
  Oncotarget.2018; 9(40): 26195.     CrossRef
• Implications of KRAS mutations in acquired resistance to treatment in NSCLC
  Marzia Del Re, Eleonora Rofi, Giuliana Restante, Stefania Crucitta, Elena Arrigoni, Stefano Fogli, Massimo Di Maio, Iacopo Petrini, Romano Danesi
  Oncotarget.2018; 9(5): 6630.     CrossRef
• Alk Immunohistochemistry is Highly Sensitive and Specific for the Detection of Alk Translocated Lung Adenocarcinomas: Lessons from An Audit of Lung Cancer Molecular Testing
  YC Kheng, K Walsh, L Williams, WA Wallace, DJ Harrison, A Oniscu
  Journal of the Royal College of Physicians of Edinburgh.2018; 48(1): 20.     CrossRef
• Targeting KRAS mutated non-small cell lung cancer: A history of failures and a future of hope for a diverse entity
  Alexios Matikas, Dimitrios Mistriotis, Vasilios Georgoulias, Athanasios Kotsakis
  Critical Reviews in Oncology/Hematology.2017; 110: 1.     CrossRef
• Clinical Outcome of ALK -Positive Non–Small Cell Lung Cancer (NSCLC) Patients with De Novo EGFR or KRAS Co-Mutations Receiving Tyrosine Kinase Inhibitors (TKIs)
  Sabine Schmid, Oliver Gautschi, Sacha Rothschild, Michael Mark, Patrizia Froesch, Dirk Klingbiel, Hermann Reichegger, Wolfram Jochum, Joachim Diebold, Martin Früh
  Journal of Thoracic Oncology.2017; 12(4): 681.     CrossRef
• EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology
  Vincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, Antoinette Lemoine, Benjamin Besse, Olaf Mercier, Élie Fadel, Peter Dorfmuller, Thierry Le Chevalier
  Pathology - Research and Practice.2017; 213(7): 793.     CrossRef
• MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values
  Geun Dong Lee, Seung Eun Lee, Doo-Yi Oh, Dan-bi Yu, Hae Min Jeong, Jooseok Kim, Sungyoul Hong, Hun Soon Jung, Ensel Oh, Ji-Young Song, Mi-Sook Lee, Mingi Kim, Kyungsoo Jung, Jhingook Kim, Young Kee Shin, Yoon-La Choi, Hyeong Ryul Kim
  Journal of Thoracic Oncology.2017; 12(8): 1233.     CrossRef
• Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02–14 Study)
  Jean-Bernard Auliac, Isabelle Monnet, Catherine Dubos-Arvis, Anne Marie Chiappa, Nathalie Baize, Suzana Bota, Alain Vergnenegre, Helene Doubre, Chrystele Locher, Acya Bizieux, Gilles Robinet, Christos Chouaid
  Targeted Oncology.2017; 12(6): 833.     CrossRef
• Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases
  Giuseppe Lo Russo, Martina Imbimbo, Giulia Corrao, Claudia Proto, Diego Signorelli, Milena Vitali, Monica Ganzinelli, Laura Botta, Nicoletta Zilembo, Filippo de Braud, Marina Chiara Garassino
  Oncotarget.2017; 8(35): 59889.     CrossRef
• Management of non-small cell lung cancer in the era of personalized medicine
  Gaetano Rocco, Alessandro Morabito, Alessandra Leone, Paolo Muto, Francesco Fiore, Alfredo Budillon
  The International Journal of Biochemistry & Cell Biology.2016; 78: 173.     CrossRef
• A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation
  Fumio Imamura, Takako Inoue, Madoka Kimura, Kazumi Nishino, Toru Kumagai
  Respiratory Medicine Case Reports.2016; 19: 137.     CrossRef